RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ATRC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for AtriCure
(Updated on Mar 28, 2024)

Sell candidate since Mar 12, 2024 Loss -12.96% PDF

The AtriCure stock price gained 0.93% on the last trading day (Thursday, 28th Mar 2024), rising from $30.14 to $30.42. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.28% from a day low at $29.61 to a day high of $30.58. The price has fallen in 7 of the last 10 days and is down by -6.46% for this period. Volume fell on the last day by -326 thousand shares and in total, 501 thousand shares were bought and sold for approximately $15.25 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.92% during the next 3 months and, with a 90% probability hold a price between $26.43 and $34.95 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ATRC Signals & Forecast

There are mixed signals in the stock today. The AtriCure stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $33.23. On a fall, the stock will find some support from the short-term average at $29.50. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Monday, March 25, 2024, and so far it has risen 7.83%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for AtriCure stock

AtriCure finds support from accumulated volume at $30.14 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.97 between high and low, or 3.28%. For the last week, the stock has had daily average volatility of 4.32%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ATRC) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect AtriCure to open at $30.20, and during the day (based on 14 day Average True Range), to move between $28.99 and $31.85, which gives a possible trading interval of +/-$1.43 (+/-4.70%) up or down from last closing price. If AtriCure takes out the full calculated possible swing range there will be an estimated 9.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $30.47 (0.16%) than the support at $30.14 (0.92%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is AtriCure stock A Buy?

AtriCure holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.689 Sell Candidate Unchanged

Predicted Opening Price for AtriCure of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$30.20 ( 0.712%) $30.42

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ATRC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 31.17 2.48 %
R2 30.80 1.26 %
R1 30.57 0.506 %
Current price: 30.42
Support S1 29.83 -1.93 %
S2 29.60 -2.68 %
S3 29.23 -3.90 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 34.00 11.77 %
R2 32.72 7.56 %
R1 30.47 0.164 %
Current price 30.42
Support S1 30.14 -0.92%
S2 28.47 -6.41%
S3 28.21 -7.26%

FAQ

What is the symbol for AtriCure Stock and on which exchange is it traded?
The symbol for AtriCure is ATRC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell AtriCure Stock?
AtriCure holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy AtriCure Stock?
AtriCure Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AtriCure Stock.

What's the current price of AtriCure Stock?
As of the end of day on the 2024-03-28, the price of an AtriCure (ATRC) share was $30.42.

What is the 52-week high and low for AtriCure Stock?
The 52-week high for AtriCure Stock is $59.61 and the 52-week low is $27.92.

What is the market capitalization of AtriCure Stock?
As of the 2024-03-28, the market capitalization of AtriCure is 1.448B.

When is the next earnings date for AtriCure?
The upcoming earnings date for AtriCure is May 07, 2024.
Click to get the best stock tips daily for free!

About AtriCure

AtriCure AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform tem... ATRC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT